Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Garbe

Showing results (271-280 of 501) with videos related to

Pageof 51
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2017
Genomics of Immunotherapy-Associated Hyperprogressors-LetterAndrea Forschner, Heike Niessner, Yvonne Möller, et al.
The Journal of Investigative Dermatology|July 25, 2017
Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma RegistryMaximilian Gassenmaier, Thomas Kurt Eigentler, Ulrike Keim, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 6, 2013
Brief S2k guidelines--Cutaneous squamous cell carcinomaHelmut Breuninger, Thomas Eigentler, Friedrich Bootz, et al.
Cancer Immunology, Immunotherapy : CII|December 24, 2016
Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma-safety and efficacy in a phase II studyBenjamin Weide, Alexander Martens, Kilian Wistuba-Hamprecht, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 10, 2019
Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapyMaria-Ioanna Stefanou, Irina Gepfner-Tuma, Cornelia Brendle, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 14, 2020
Dermatofluoroscopy diagnostics in different pigmented skin lesions: Strengths and weaknessesMaja Ann Hofmann, Ulrike Keim, Agata Jagoda, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 27, 2020
Maja Ann Hofmann, Ulrike Keim, Agata Jagoda, et al.
Frontiers in Oncology|September 10, 2014
Epigenetic impacts of ascorbate on human metastatic melanoma cellsSascha Venturelli, Tobias W Sinnberg, Alexander Berger, et al.
Journal of the American Academy of Dermatology|February 1, 2019
Age as key factor for pattern, timing, and extent of distant metastasis in patients with cutaneous melanoma: A study of the German Central Malignant Melanoma RegistryMaximilian Gassenmaier, Ulrike Keim, Ulrike Leiter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 20, 2017
Impact of <sup>18</sup>F-FDG-PET/CT on surgical management in patients with advanced melanoma: an outcome based analysisAndrea Forschner, Susann-Cathrin Olthof, Brigitte Gückel, et al.
Pageof 51

Showing results (271-280 of 501) with videos related to

Sort By:
Pageof 51
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2017
Genomics of Immunotherapy-Associated Hyperprogressors-LetterAndrea Forschner, Heike Niessner, Yvonne Möller, et al.
The Journal of Investigative Dermatology|July 25, 2017
Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma RegistryMaximilian Gassenmaier, Thomas Kurt Eigentler, Ulrike Keim, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 6, 2013
Brief S2k guidelines--Cutaneous squamous cell carcinomaHelmut Breuninger, Thomas Eigentler, Friedrich Bootz, et al.
Cancer Immunology, Immunotherapy : CII|December 24, 2016
Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma-safety and efficacy in a phase II studyBenjamin Weide, Alexander Martens, Kilian Wistuba-Hamprecht, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 10, 2019
Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapyMaria-Ioanna Stefanou, Irina Gepfner-Tuma, Cornelia Brendle, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 14, 2020
Dermatofluoroscopy diagnostics in different pigmented skin lesions: Strengths and weaknessesMaja Ann Hofmann, Ulrike Keim, Agata Jagoda, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 27, 2020
Maja Ann Hofmann, Ulrike Keim, Agata Jagoda, et al.
Frontiers in Oncology|September 10, 2014
Epigenetic impacts of ascorbate on human metastatic melanoma cellsSascha Venturelli, Tobias W Sinnberg, Alexander Berger, et al.
Journal of the American Academy of Dermatology|February 1, 2019
Age as key factor for pattern, timing, and extent of distant metastasis in patients with cutaneous melanoma: A study of the German Central Malignant Melanoma RegistryMaximilian Gassenmaier, Ulrike Keim, Ulrike Leiter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 20, 2017
Impact of <sup>18</sup>F-FDG-PET/CT on surgical management in patients with advanced melanoma: an outcome based analysisAndrea Forschner, Susann-Cathrin Olthof, Brigitte Gückel, et al.
Pageof 51